Interleukin-2 (high-dose)
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Interleukin-2 (high-dose), covering 2013-04-10 to 2026-08-06. Get the full timeline:
Most recent: Clinical Trial Results: High Dose IL-2 in Combination With Anti-PD-1 [Phase 2]